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Introduction
Glycosylphosphatidylinositol (GPI) is a glycolipid widely 
used among eukaryotes as membrane anchors for many cell 
surface proteins (Ferguson et al., 2009). GPI is biosynthesized 
and transferred to proteins in the ER. After GPI attachment to 
proteins, remodeling of GPI moieties on GPI-anchored pro-
teins (GPI-APs) occurs during transport (Tanaka et al., 2004; 
Tashima et al., 2006; Maeda et al., 2007; Fujita et al., 2009). 
Those remodeling reactions confer unique features on GPI-
APs, including lipid raft association on the membrane (Maeda 
et al., 2007). Another feature of GPI-APs is their cleavage 
within the GPI moiety by GPI-cleaving enzymes and shedding 
from the membrane (Fujihara and Ikawa, 2016). The number 
of proven examples of GPI-cleaving enzyme–mediated GPI-AP 
shedding under physiological conditions is small (Fujihara and 
Ikawa, 2016). Theoretically, the shedding of GPI-APs has two 
biological modes of action: (1) shed GPI-APs act at sites remote 
from the original cells and affect the fate of other cells; and 
(2) the initiation of specific activities suppressed by inhibitory 
GPI-APs on the same cells (Fujihara and Ikawa, 2016). There 
are two examples of the latter mode; shedding of TEX101 from 
sperm by testis type of angiotensin-converting enzyme is in-
volved in sperm maturation (Kondoh et al., 2005; Fujihara et 
al., 2013b) and shedding of a metalloprotease inhibitor RECK 
by glycerophosphodiester phosphodiesterase 2, resulting in 
metalloprotease-mediated degradation of a Notch ligand DLL1, 
which, in turn, reduces Notch signaling in adjacent progenitor 
cells to induce differentiation into neurons (Park et al., 2013). 
A clear example of the former mode has not been demonstrated 
(Fujihara and Ikawa, 2016).
During embryonic development, Nodal signaling is re-
quired for many aspects, including anterior–posterior axis 
patterning, mesoderm induction, and left–right axis specifica-
tion (Tian and Meng, 2006; Shen, 2007). CRI PTO, a GPI-AP 
(Minchiotti et al., 2000), forms a complex with type I and II 
activin receptors for Nodal on the membrane and induces 
cell-autonomous signaling (Yan et al., 2002). In addition, a 
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biologically active, soluble form of CRI PTO is generated by 
GPI cleavage (Watanabe et al., 2007). The soluble form of CRI 
PTO is required for non–cell autonomous CRI PTO-Nodal sig-
naling in mammalian cells (Yan et al., 2002; Parisi et al., 2003), 
which is critical for axial mesendoderm formation (Chu et al., 
2005). However, molecular mechanisms of CRI PTO shedding 
have not been clarified (Minchiotti et al., 2001; Yan et al., 2002).
We previously reported that post-glycosylphosphatidyli-
nositol attachment to proteins 3 (PGAP3) is a Golgi-resident, 
GPI-specific phospholipase A2 (GPI-PLA2) involved in fatty 
acid remodeling of GPI-APs (Fujita et al., 2006; Maeda et al., 
2007). In the remodeling process, PGAP3 is required for the 
removal of an unsaturated fatty acid from the sn-2 position. A 
bioinformatics approach revealed that PGAP3, Per1p (a yeast 
homologue of PGAP3), and alkaline ceramidase belong to a 
membrane-bound hydrolase superfamily, termed CRE ST (al-
kaline ceramidase, PAQR receptor, Per1, SID-1, and TMEM8) 
(Pei et al., 2011). In this study, we identified an uncharacter-
ized gene, TMEM8A, here renamed PGAP6, which has close 
similarity to PGAP3 in the superfamily members. Our data 
show that PGAP6 is a GPI-PLA2 expressed on the cell surface, 
sheds CRI PTO as an active Nodal coreceptor, and is critical for 
anterior–posterior axis formation in embryonic development 
through modulating CRI PTO-Nodal signaling.
Results
TMEM8A/PGAP6 is involved in GPI-AP 
processing at the cell surface
CRE ST members share seven predicted transmembrane seg-
ments containing five conserved residues (three His, Asp, 
and Ser). TMEM8 family proteins, which are located near 
the PGAP3 gene cluster, are conserved in vertebrates and in-
clude three members (TMEM8A, B, and C) in mammals (Pei 
et al., 2011). Among them, TMEM8A has conserved putative 
catalytic amino acids within transmembrane domains at the 
C-terminal regions (Fig.  1  A). In addition, TMEM8A has an 
unannotated N-terminal region and an EGF-like domain after 
the signal sequence for ER insertion. TMEM8A was detected 
by anti-TMEM8A mAb on human embryonic carcinoma NTE 
RA2 cells and HEK293T cells by flow cytometry, indicating 
that TMEM8A, unlike Golgi-resident PGAP3, is expressed on 
the cell surface (Fig. 1 B). To further characterize TMEM8A, 
TMEM8A or HA-tagged TMEM8A (HA-TMEM8A) was ex-
pressed in CHO 3B2A cells. Nontagged TMEM8A was de-
tected on the cell surface (Fig. 1 C). HA-TMEM8A was also 
detected on the cell surface (Fig. 1 D) and appeared in 120- and 
90-kD bands (Fig. 1 E, lane NT). The 120-kD band was sensi-
tive to PNGase and resistant to EndoH, indicating that it rep-
resents a mature cell surface TMEM8A protein (Fig. 1 E, lanes 
EnH and PNG). The 90-kD band was sensitive to both PNGase 
and EndoH, indicating that it has immature N-glycans. Subcel-
lular fractionation and microscopic observation confirmed that 
the 120-kD protein is localized in the plasma membrane (PM) 
and that the 90-kD protein is localized in the ER (Fig. 1, F and 
G). The ER form might be an intermediate during transport.
We tested whether TMEM8A is involved in GPI-AP pro-
cessing using CHO 3B2A cells overexpressing HA-TMEM8A. 
TMEM8A significantly reduced amounts of two GPI-APs, 
CD59 and decay-accelerating factor (DAF), whereas another 
GPI-AP urokinase-type plasminogen activator receptor (uPAR) 
was only slightly decreased (Fig. 2 A). Because TMEM8A has 
similarity to PGAP3 and decreased the levels of GPI-APs, we 
renamed it PGAP6 (for post-GPI attachment to proteins 6) as a 
protein involved in the processing of GPI-APs.
Because different GPI-APs showed different sensitivity to 
PGAP6, we searched for a sensitive substrate GPI-AP, espe-
cially among those known to be released from the cell surface, 
and found CRI PTO is highly sensitive (Fig.  2  B). Strikingly, 
CRY PTIC, another GPI-AP and a close homologue of CRI PTO, 
was not decreased from the cell surface even with overexpres-
sion of PGAP6 (Fig. 2 B), indicating that PGAP6 has specificity 
and selectivity against substrate GPI-APs.
We next addressed the molecular mechanisms of de-
creased GPI-APs on the cell surface. CRI PTO exists in solu-
ble and membrane-bound forms (Yan et al., 2002; Watanabe 
et al., 2007). Because CRI PTO was constantly released into 
the medium when CRI PTO-transfected HEK293T cells were 
cultured in the presence of 10% FCS, we analyzed the effect 
of PGAP6 using serum-free medium. Western blotting re-
vealed 23- and 21-kD bands of HA-CRI PTO (Fig. 2 C). The 
23-kD band represents a mature protein bearing a complex type 
N-glycan, whereas the 21-kD band represents the immature, 
ER form of HA-CRI PTO bearing EndoH-sensitive N-glycan 
(Fig. S1). When PGAP6 was overexpressed, the mature form 
of CRI PTO was nearly completely lost, whereas the ER form 
of CRI PTO remained (Fig.  2  C, left, top panel). The surface 
expression of CRI PTO was strongly reduced by PGAP6 over-
expression (Fig. 2 C, top right) and secretion of HA-CRI PTO 
was enhanced (Fig. 2 C, left, bottom panel).
NTE RA2 cells express both CRI PTO and PGAP6 
(Fig.  2  D, top). CRI PTO was released from NTE RA2 cells 
into medium (Fig.  2  D, bottom left, lane siCon), and knock-
down of PGAP6 almost completely inhibited the release (lane 
siPGAP6), indicating that endogenous PGAP6 released en-
dogenous CRI PTO from the cell surface. After knockdown of 
PGAP6, the surface expression of endogenous CRI PTO in-
creased by ∼40% (Fig. 2 D, top and bottom right, histogram 
and quantified data, respectively).
Knockdown of PGAP6 in HEK293T cells also greatly de-
creased the release of HA-CRI PTO into the medium (Fig. 2 E, 
bottom left and right, Western and quantified data, respec-
tively). After knockdown of PGAP6, the surface expression of 
HA-CRI PTO increased by ∼50% (Fig. S1 B). Specificity of 
PGAP6 knockdown was confirmed by rescue of CRI PTO re-
lease by siRNA-resistant PGAP6 but not by siRNA-resistant 
catalytic-dead PGAP6 (D610A; Fig. S1 C). The secretion of 
HA-CRI PTO was also inhibited by PGAP6 knockdown even 
in medium containing 10% FCS (Fig. S1 D), suggesting that 
the effect of serum on CRI PTO release might be dependent on 
PGAP6 activity. We next analyzed whether amino acid resi-
dues of PGAP6 conserved in the CRE ST family are required 
for the release of GPI-APs. All of the point mutants except 
the S584A mutant lost CRI PTO-releasing activity (Fig. S2), 
suggesting that the conserved amino acids are important for 
PGAP6 enzymatic activity.
PGAP6 has GPI-PLA2 activity
To determine whether PGAP6 is GPI-PLA2 as expected from 
similarity to PGAP3, we used partitioning with Triton X-114. 
Because conditions of mass spectrometry (MS) analysis of 
the C-terminal peptides bearing lipid-containing GPI have not 
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whether GPI-APs possess lipid moieties. Most CRI PTO re-
leased by PGAP6 was partitioned into the aqueous phase, and 
only a small amount was partitioned into the detergent phase, 
suggesting released GPI-APs did not have a lipid chain (Fig. 
S3 A). We then used His-Flag-GST-Flag–tagged CD59 (HF-
GF-CD59) to determine the structure of the GPI moiety in re-
leased GPI-APs. HFGF-CD59 was released by overexpression 
of PGAP6 (Fig. S3 B, right). The GPI structures of released 
HFGF-CD59 were analyzed by MS. Four peaks containing a 
C-terminal peptide bearing GPI moiety were detected. In the 
second MS, all four peaks gave characteristic fragments de-
rived from a GPI anchor, such as mass-to-charge ratio (m/z) 
447+ and 609+. Based on the profile of the fragment ions, we 
concluded that the C-terminal peptide of the parent mass (m/z 
1,226.442+) had a GPI glycan core structure without a phos-
pholipid (Fig. 3 A). Three other peaks contained the same GPI 
core structure and a side chain linked to the first mannose with 
different sugar extensions known to occur in mammalian GPIs 
(Paulick and Bertozzi, 2008; Fig. S3 C). All four peaks were 
generated by hydrolysis between inositol and phosphate. There-
fore, the released HFGF-CD59 was the product of phospholi-
pase D (PLD)–mediated cleavage.
These results suggest that if PGAP6 is a GPI-PLA2, lyso–
GPI-AP generated by PGAP6 is subsequently cleaved by PLD. 
We next assessed this scenario by determining the number of 
fatty chains linked to GPI-APs in cells overexpressing PGAP6. 
Figure 1. TMEM8A, a homologue of PGAP3, 
is expressed on the cell surface. (A) Compari-
son of human PGAP3 and TMEM8A proteins. 
Conserved residues within transmembrane 
regions TM2, TM3, and TM7 are indicated. 
Amino acid numbers are above the models. 
(B) Flow cytometric analysis of endogenous 
TMEM8A on HEK293T (top) and NTE RA2 
(bottom) cells. Shaded, anti-TMEM8A; dashed 
lines, isotype controls. Geometric means of 
mean fluorescence intensity (geo.MFI) and 
SD of three independent measurements and 
p-values (Student’s t test) are shown on the 
right. (C) Immunofluorescence visualization 
of cells-surface TMEM8A. 3B2A cells express-
ing TMEM8A and Lyn11-mRFP (PM marker) 
were fixed and stained with anti-TMEM8A. 
(D) Flow cytometric analysis of HA-TMEM8A 
on CHO 3B2A cells. Cells transfected with 
vector (top) or HA-TMEM8A (bottom) were 
stained with anti-HA. Shaded, anti-HA; solid 
lines, isotype controls. For HA-TMEM8A–trans-
fected cells, geo.MFI with SD of three inde-
pendent measurements and p-value (Student’s 
t test) is shown on the right. (E) Glycosylation 
of TMEM8A. Lysates of cells expressing HA-
TMEM8A were treated with buffer (NT), Endo 
H (EnH), or PNGase F (PNG) and analyzed 
by Western blotting. GAP DH, loading con-
trols. Closed arrow, 120-kD form with com-
plex N-glycan; open arrow, 90-kD form with 
EnH-sensitive N-glycan; arrowhead, a degly-
cosylated form. (F) Subcellular fractionation of 
TMEM8A. Lysates of cells expressing His-Flag–
tagged TMEM8A (HF-TMEM8A) were fraction-
ated by sucrose-gradient centrifugation and 
Western blotted. Organelle markers: Na/K 
ATPase 1, PM; ribophorin I, ER; syntaxin 6, 
Golgi. Closed and open arrows, mature PM 
form and immature ER form of HF-TMEM8A, 
respectively. A band at 40 kD is likely de-
graded HF-TMEM8A. Representative data of 
two independent experiments. (G) Immuno-
fluorescence visualization of an ER form of 
TMEM8A. 3B2A cells expressing HF-TMEM8A 
and RFP-KDEL (ER marker) or GPP130 (Golgi 
marker) were fixed and stained with anti-Flag 
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Figure 2. TMEM8A is involved in GPI-AP processing. (A) TMEM8A/PGAP6 overexpression selectively decreased some GPI-APs. Right: Western blotting 
of 3B2A cells stably transfected with vector or HA-PGAP6. Left: flow cytometry of the same cells. Black lines, vector-transfected cells; shaded areas, cells 
expressing HA-PGAP6; gray lines, vector-transfected cells stained with second antibody only; gray dashed lines, HA-PGAP6–transfected cells stained with 
second antibody only. PGAP6 decreased CD59 to 55%, DAF to 64%, and uPAR to 96% of wild-type levels. Geometric means of mean fluorescence intensity 
(geo.MFI) with SD of three independent measurements and p-values (Student’s t test) are shown to the right of each histogram. (B) CRI PTO is very sensitive, 
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For this, we used hydrophobic chromatography with octyl-Sep-
harose. The reporter GPI-AP VSVGts-FF-mEGFP-GPI consists 
of the extracellular domain of temperature-sensitive vesicular 
stomatitis virus G protein, a furin cleavage site, a Flag tag, mod-
ified EGFP, and a GPI attachment signal (Tashima et al., 2006). 
Upon arrival at the trans-Golgi network, the reporter becomes a 
smaller molecule termed Flag-mEGFP-GPI by furin cleavage. 
Sufficient amounts of Flag-mEGFP-GPI were isolated from 
PGAP6-overexpressed cell lysates for chromatographic analy-
sis. Flag-mEGFP-GPI harboring two fatty chains isolated from 
wild-type cells was eluted in fractions 15 and 16 (Fig. 3 B, a), 
whereas Flag-mEGFP-GPI from PGAP6-overexpressing cells 
was eluted in fractions 13 and 14, one fraction earlier than the 
wild-type protein (Fig.  3 B, b). This suggested that one fatty 
acid was removed by PGAP6. To confirm this, Flag-mEGFP-
GPI from wild-type cells was treated with honeybee PLA2 
and subjected to the same column either alone or after mixing 
with Flag-mEGFP-GPI from PGAP6-overexpressing cells. As 
shown in Fig. 3 B (c and b + c), they were coeluted. These re-
sults suggest that PGAP6 has GPI-PLA2 activity.
We next analyzed whether GPI-PLD (GPLD1) is in-
volved in the PGAP6-dependent release process. We analyzed 
GPLD1-knockout (KO) HEK293 cells in serum-free medium 
to eliminate the effects of GPI-PLD in the serum. Flow cyto-
metric analysis showed the surface expression of CRI PTO in 
GPLD1-KO expressing PGAP6 was reduced similar to that in 
wild-type cells expressing PGAP6 (Fig. 3 C). Therefore, GPI-
PLD was not required for PGAP6-dependent CRI PTO release 
itself. However, a significant fraction of CRI PTO released by 
PGAP6 in the absence of GPI-PLD was partitioned to the deter-
gent phase (Fig. 3 D, right, middle panel), indicating that CRI 
PTO bearing lyso-GPI released from the cell membrane is even-
tually converted to the lipid-free form by the action of GPI-PLD 
or other PLD active on lyso-GPI (Fig. 4 A).
Shedding of CRI PTO by PGAP6 modulates 
Nodal signaling: Shed CRI PTO acted on 
other cells as a Nodal coreceptor, whereas 
cell-associated CRI PTO activity was 
decreased by coexpression of PGAP6
CRI PTO functions as an essential coreceptor of a heteromeric 
receptor for TGF-β ligands, including Nodal (Shen and Schier, 
2000; de Castro et al., 2010). CRI PTO could act as a Nodal 
coreceptor in two ways, either in cis or in trans. We first an-
alyzed the effects on the trans functions of CRI PTO. CRI 
PTO-expressing HEK293 cells were cultured, and activity of 
CRI PTO released into the culture media was assessed by incu-
bating the culture media with responder cells expressing Nodal 
receptor and (n2)7-luciferase reporter (Saijoh et al., 2000). 
CRI PTO released in the absence of exogenous PGAP6 showed 
Nodal signaling activity in trans, which was enhanced by the 
expression of PGAP6 (Fig. 5 A). In contrast, culture medium 
collected from PGAP6 knockdown cells did not activate Nodal 
signaling in trans (Fig.  5  B). Endogenous CRI PTO released 
from NTE RA2 cells also had trans Nodal coreceptor activity, 
which was inhibited by knockdown of PGAP6 (Fig. 5 C). These 
results indicate that CRI PTO released by PGAP6 has an ability 
to function as a Nodal coreceptor on other cells.
Because PGAP6 expression reduced cell surface 
CRI PTO, we investigated whether cis Nodal signaling was af-
fected by PGAP6. There was a 2.5-fold increase in reporter re-
sponse with HA-CRI PTO expression. This increased response 
was decreased by cotransfection of PGAP6 with HA-CRI PTO 
(Fig. 5 D), although this inhibition was not complete, probably 
because of the trans activity of secreted HA-CRI PTO. More-
over, HA-CRI PTO induced the phosphorylation of Smad2 in 
HEK293T cells, and this phosphorylation was impaired in cells 
cotransfected with PGAP6 (Fig. 5 E). These results indicate that 
PGAP6 modulates both cis and trans CRI PTO-dependent Nodal 
signaling through cleavage of the GPI anchor of CRI PTO.
CRI PTO shedding by PGAP6 is inhibited by 
mutations in PGAP1 and PIGN
It was reported that two recessive mutations in GPI biosynthetic 
genes Pign and Pgap1 in mice caused defective Cripto signal-
ing and holoprosencephaly, a form of impaired development of 
the forebrain (McKean and Niswander, 2012). PIGN (Pign in 
mice) is required for the addition of an ethanolamine phosphate 
side chain to the first mannose on GPI during biosynthesis in the 
ER (Hong et al., 1999), and PGAP1 (Pgap1 in mice) acts as a 
GPI-inositol deacylase after GPI transfer to proteins (Tanaka et 
al., 2004; Fig.  4). These observations prompted us to analyze 
whether PGAP6 processes and releases CRI PTO in the PIGN and 
PGAP1 mutant backgrounds. CRI PTO transfected into PGAP1 
mutant cells was expressed on the cell surface at levels substan-
tially lower than those on wild-type cells (Fig. 6 A). The slow 
transport of CRI PTO from the ER might explain the observed 
phenotypes (Tanaka et al., 2004). When PGAP6 was cotrans-
fected with CRI PTO, the expression of CRI PTO on the surface 
of PGAP1 mutant CHO C10 cells was only slightly decreased 
(statistically not significant), whereas CRI PTO on parental CHO 
3B2A cells was reduced significantly (Fig. 6 A). Western blot-
ting also showed that CRI PTO was not released into the culture 
medium in PGAP1 mutant cells expressing PGAP6 (Fig.  6 B, 
bottom). The lipid properties of GPI-APs in PGAP1 mutant 
cells were then analyzed by octyl-Sepharose chromatography 
(top and bottom) Flow cytometry. The cell surface levels of CRY PTIC as assessed by anti-HA staining and FACS were similar with and without PGAP6 over-
expression, whereas CRI PTO levels were drastically decreased with PGAP6. Both CRI PTO and CRY PTIC were similarly sensitive to PI-PLC. Geo.MFI with SD 
of three independent measurements and p-values (Student’s t test) are shown to the right of each histogram in top and bottom panels. (middle) Western blot 
data showing PGAP6 expression in PGAP6-transfected cells. (C) CRI PTO is shed into the culture medium by PGAP6. HEK293T cells transiently expressing 
HA-CRI PTO alone or with PGAP6 were cultured in serum-free medium for 6 h. The cells were lysed, and culture supernatants were immunoprecipitated by 
anti-HA. The cell lysates and immunoprecipitates were analyzed by Western blotting (left). GAP DH, loading controls. Flow cytometry confirmed a nearly 
complete loss of mature, cell-surface HA-CRI PTO by PGAP6 (top right). Black line, HA-CRI PTO alone; shaded area, HA-CRI PTO with PGAP6; gray dashed 
line, negative staining. Geo.MFI with SD of three independent measurements and p-value (Student’s t test) is shown below the histogram at bottom right. 
(D) Knockdown of PGAP6 in NTE RA2 cells inhibited the release of CRI PTO into the medium. NTE RA2 cells were transfected with control RNA (siCon) or 
siRNA against PGAP6 (siPGAP6). NTE RA2 cells were stained for PGAP6 to assess knockdown (top left) and for CRI PTO to assess changes (top right). 
Cell lysates and culture media were analyzed by Western blotting (bottom left). Secretion of CRI PTO into the medium was almost completely inhibited by 
siPGAP6 (bottom left). The cell surface CRI PTO was increased by 40% after siPGAP6 treatment (P = 0.041 in Student’s t test). (E) Knockdown of PGAP6 
in HEK293T cells expressing HA-CRI PTO. Knockdown efficiency was assessed at mRNA level and is shown (top right). Release of HA-CRI PTO was signifi-
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(Fig. 6 C). Flag-mEGFP-GPI proteins from PGAP1 mutant cells 
were mainly eluted in fraction 16, indicating that they were more 
hydrophobic than those from wild-type cells because of an addi-
tional acyl chain (Fig. 3 B [a] vs. Fig. 6 C [a]). PLA2 treatment 
of Flag-mEGFP-GPI prepared from PGAP1 mutant cells resulted 
in elution in more hydrophilic fractions (Fig. 6 C, c). Flag-mEG-
FP-GPI from PGAP1 mutant cells expressing PGAP6 was eluted 
earlier than that from PGAP1 mutant cells with an empty vector 
(Fig. 6 C, b). The eluted position was similar to that of wild type 
(Fig. 3 B, a), suggesting PGAP6 cleaved inositol-acylated GPI-
APs to generate inositol-acylated lyso–GPI-APs. These results 
indicate that inositol-acylated GPI-AP is sensitive to PGAP6 but 
is not secreted into the medium because of the additional acyl-
chain linked to inositol (Fig. 4, A and B). Consistent with a lack 
of CRI PTO secretion, Nodal signaling was not induced by cul-
ture media from PGAP1 mutant cells (Fig. 6 D).
Figure 3. Mechanisms of CRI PTO shedding. (A) PLD-mediated GPI cleavage indicated by structural analysis of secreted GPI-AP. 3B2A cells stably ex-
pressing HFGF-CD59 were transfected with PGAP6. After 72 h, secreted HFGF-CD59 was purified from culture medium, digested in-gel by trypsin, and 
analyzed by LC-ESI-MS/MS. MS/MS analysis of GPI-bearing C-terminal peptide (m/z = 1,226.442+) indicated PLD-mediated cleavage of GPI. See also 
Fig. S3. (B) Cell-associated GPI-AP from PGAP6-expressing cells contained lyso-GPI as shown by hydrophobic chromatography. 3B2A cells stably express-
ing vector (a: +Vec) or PGAP6 (b: +PGAP6) were transiently transfected with VSVGts-FF-mEGFP-GPI. Flag-mEGFP-GPI purified from cell lysates was chro-
matographed in an Octyl-FF column with 1-propanol gradient. Fractions were analyzed by Western blotting with anti-Flag antibody. The standard lyso-form 
was prepared by treating Flag-mEGFP-GPI with honeybee PLA2 and analyzed alone (c: +Vec [treat with PLA2]) or after mixing with sample b (b + c Mix). 
(C) GPI-PLD is dispensable for CRI PTO release from the cell surface. Wild-type, GPLD1-KO, and GPLD1 rescued GPLD1-KO HEK293 cells, transiently ex-
pressing HA-CRI PTO with vector (black lines) or PGAP6 (shaded areas), were analyzed for CRI PTO by flow cytometry. Dashed lines, samples without first 
antibody. CRI PTO on GPLD1-KO cells was equally sensitive to PGAP6-dependent shedding. Geometric means of mean fluorescence intensity (geo.MFI) with 
SD of three independent measurements and p-values (Student’s t test) are shown on the right. CRI PTO geo.MFI of wild-type, GPLD1 KO, and GPLD1-rescued 
GPLD1 KO cells after vector transfection were not significantly different. (D) GPI-PLD is involved in the cleavage of lyso-GPI. The same cells as shown in C 
were cultured in serum-free medium for 6 h. Cellular and secreted HA-CRI PTO from vector- (Control) and PGAP6-transfected (PGAP6) cells were partitioned 
into the aqueous (A) and detergent (D) phases after Triton X-114 solubilization. (right) Longer exposure for samples from PGAP6-transfected cells. CRI PTO 
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It is known that GPI-APs, lacking a first mannose–linked 
ethanolamine phosphate side chain, are expressed on the PIGN-
null cell surface, although usually at decreased levels than 
normal (Hong et al., 1999; Ohba et al., 2014). When CRI PTO 
was transfected into PIGN-KO and wild-type HEK293 cells, 
CRI PTO on the PIGN-KO cells, although its surface expression 
was slightly lower than that on wild-type cells, was resistant 
to PGAP6 (Fig.  6  E, bottom). Western blotting also showed 
that CRI PTO was not secreted into the medium by PGAP6 
(Fig.  6  F), suggesting that the ethanolamine phosphate side 
chain was critical for cleavage by PGAP6. Culture media from 
PIGN-KO cells expressing CRI PTO with PGAP6 did not in-
duce Nodal signaling (Fig.  6  G). These results indicate that 
mutations in PGAP1 and PIGN impaired PGAP6-dependent 
CRI PTO secretion (Fig. 4, B and C).
Pgap6 is critical for the early 
embryogenesis in mouse
Cripto plays a key role in mouse embryo by acting as a Nodal 
coreceptor (Ding et al., 1998; Xu et al., 1999). To confirm that 
Pgap6 is expressed in embryo when Cripto functions, we de-
termined Pgap6 transcripts in day 6.2 embryos (E6.2) by in 
situ hybridization. Pgap6 was weakly but widely expressed in 
epiblasts (Fig. 7, A and B). Cripto was expressed in E6.2 epi-
blasts, forming a gradient from high expression in the proximal 
region to weaker expression in the distal region (Fig. 7, E and 
F; Ding et al., 1998). In E6.7 embryos, Pgap6 transcript levels 
decreased (Fig. 7, G and H), and in E7.7, they were below the 
detection limit of in situ hybridization (not depicted), suggest-
ing that Pgap6 is transiently coexpressed with Cripto in epi-
blasts at 6.2 d postcoitum.
Figure 4. Schematic of PGAP6 action on CRI PTO. (A) Steps in 
the shedding of CRI PTO from PGAP6-expressing cells. (B) PGAP6 
cleaves but does not shed CRI PTO from PGAP1 mutant cells. 
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To determine roles of Pgap6 in vivo, we generated and an-
alyzed Pgap6 KO embryos (Fig. S4). All of the Pgap6 KO ho-
mozygotes except one were embryonic lethal. In wild-type day 
6.7 embryos, Cerberus-like (Cerl) was expressed in the anterior 
visceral endoderm during early gastrulation, and Brachyury, 
a marker of the primitive streak, was expressed in primitive 
streak (Belo et al., 1997; Inman and Downs, 2006; Fig. 7 M). 
In contrast, 3 of 13 Pgap6 KO embryos at E6.7 showed an-
terior–posterior axis defect; the Cerl was expressed in distal 
visceral endoderm, and Brachyury was broadly localized in a 
proximal area near the embryonic/extraembryonic constriction 
(Fig. 7 N). These phenotypes, especially impaired anterior shift 
of Cerl, are common with Cripto KO embryos (Ding et al., 
1998). In E8.0, growth of Pgap6 KO embryos was not seen, and 
their regression was observed. The rest of Pgap6 KO embryos 
at E6.7 did not show anterior–posterior axis defect (Fig. 7 O). 
In E9.0 and E10.0 of most Pgap6 KO, embryonic development 
was ceased (Fig. S4). These data strongly suggest that Pgap6 is 
critical for Cripto function and regulates the anterior–posterior 
axis formation in embryos.
Discussion
GPI is a cleavable membrane anchor that regulates localization 
and function of proteins modified with GPI. The major findings 
of this study were the identifications of PGAP6 as a cell-sur-
face GPI anchor–processing enzyme with GPI-PLA2 activity 
and of CRI PTO, a GPI-AP required for Nodal signaling, as a 
sensitive substrate of PGAP6. CRI PTO was processed and re-
leased by PGAP6 expressed endogenously in human embryonic 
carcinoma cell NTE RA2. In contrast, CRY PTIC, a GPI-AP that 
makes the EGF-CFC family with CRI PTO (de Castro et al., 
2010), was almost completely resistant to PGAP6 even at over-
expressed levels. CD59 and DAF were partially sensitive, and 
uPAR was nearly completely resistant to overexpressed PGAP6. 
Therefore, PGAP6 appeared to be a highly selective GPI-PLA2 
against CRI PTO. It seems that PGAP6 recognizes not only GPI 
moiety but also protein structure. We found PGAP6 bearing im-
mature N-glycans in the ER. Because a fraction of CRI PTO had 
immature N-glycans suggesting an ER form, it should be rig-
orously established whether processing of CRI PTO by PGAP6 
Figure 5. CRI PTO shed by PGAP6 acts as a 
Nodal coreceptor in trans. (A) Nodal core-
ceptor activity of shed CRI PTO. HEK293 cells 
transiently expressing HA-CRI PTO with vec-
tor or PGAP6 were used as producing cells. 
HEK293 cells bearing Nodal signal transduc-
tion system were used as responder cells. After 
6-h culture of the producing cells in serum-free 
medium, culture supernatants were incubated 
with responder cells in the presence or ab-
sence of Nodal for 12 h. Data shown are the 
mean ± SD of three independent experiments 
(Student’s t test). (B and C) PGAP6-knockdown 
HEK293 and NTE RA2 cells do not shed ac-
tive CRI PTO. HEK293 cells stably expressing 
HA-CRI PTO (B) and NTE RA2 cells (C) were 
transfected with control RNA or siRNA against 
PGAP6 and used as producing cells. Culture 
supernatants were assayed for CRI PTO ac-
tivity as described in the legend to A.  Data 
shown are the mean ± SD of three indepen-
dent experiments (Student’s t test). (D and E) 
Cell-associated Nodal signaling by CRI PTO is 
inhibited by PGAP6. HEK293T cells bearing 
a Nodal-responsive (n2)7-luc reporter system 
were transfected with CRI PTO with or without 
PGAP6. At 24 h after transfection, cells were 
incubated without or with Nodal for 6 h, and 
luciferase activities were measured. Data 
shown in D represent the mean ± SD of three 
independent experiments (Student’s t test). The 
same set of cells was also harvested after 1-h 
treatment with Nodal and Smad2 phosphor-
ylation was determined (E). Smad2-P to total 
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Figure 6. Mutations in PGAP1 and PIGN inhibited shedding of CRI PTO by PGAP6. (A and B) CRI PTO was not shed by PGAP6 from PGAP1 mutant cells. 
3B2A or PGAP1 mutant CHO cells stably expressing HA-CRI PTO were electroporated with vector or PGAP6. The surface expression of HA-CRI PTO was 
analyzed by flow cytometry (A). Shaded areas, cells carrying vector; black lines, cells carrying PGAP6; dashed lines, cells stained without first IgG. Geo-
metric means of mean fluorescence intensity (Geo.MFI) and SD of three independent experiments are shown on the right (Student’s t test). The cell lysates 
and medium samples immunoprecipitated with anti-HA were detected with the indicated antibodies (B). (C) Analysis of GPI-AP lipid structure in PGAP1 
mutant cells. PGAP1 mutant cells stably expressing vector (a: +Vec) or PGAP6 (b: +PGAP6) were transiently transfected with VSVGts-FF-mEGFP-GPI and 
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occurs only at the cell surface or if it could also occur in other 
locations within the secretory pathway.
We showed that CRI PTO shed by PGAP6 was active as a 
Nodal coreceptor and that PGAP6-mediated release of CRI PTO 
reduced Nodal signaling in cells on which CRI PTO was ex-
pressed. Furthermore, Pgap6 was involved, similarly to Cripto, 
in correct formation of the anterior–posterior axis in mouse em-
bryos, indicating that at least one critical function of PGAP6 
is to shed CRI PTO. This is a clear example of one of the two 
biological functions of GPI-AP shedding, namely, shed GPI-AP 
functions at cells different from the cell on which the GPI-AP 
was originally expressed.
We used an exon-trap construct to disrupt Pgap6 in mak-
ing the Pgap6-KO mice. A leakiness of the exon trap seems 
to be the basis of the variable phenotypes of the Pgap6-KO 
mice, namely, of 244 pups born from crosses of heterozygous 
mice, 1 was homozygous (Fig. S4), and only 3 of 13 homo-
zygous embryos had abnormal anterior–posterior axis forma-
tion (Fig.  7). All of the studied homozygous Pgap6 KO that 
passed the stage of anterior–posterior axis formation died be-
fore day 9.  It seems, therefore, that Pgap6 has roles in other 
Nodal-dependent processes.
It has been reported that defects in GPI–ethanolamine 
phosphate transferase I, Pign, and GPI–inositol deacylase 
Pgap1 perturbed Cripto signaling during forebrain development 
and caused holoprosencephaly (McKean and Niswander, 2012). 
We found that the PGAP6-mediated release of CRI PTO was 
negligible in cells defective in PGAP1 and PIGN. It is possible 
that the phenotypes of Pgap1 and Pign mutant mice could be 
caused by inefficient Cripto secretion by Pgap6.
We identified three steps in the generation of hydrophilic 
CRI PTO from the surface (Fig. 4). First, an acyl-chain at the sn-2 
position of GPI in CRI PTO is cleaved by PLA2 activity of PGAP6, 
generating a lyso-form of CRI PTO (step 1). Lyso-CRI PTO is not 
stable on the membrane and is shed into the medium (step 2). 
Shed lyso-CRI PTO is further cleaved by PLD in the medium 
(step 3). GPI-PLD accounts for a part of the PLD activity acting 
in step 3. GPI-PLD cannot efficiently cleave GPI-APs associated 
with the membrane and requires detergents for efficient cleav-
age (Low and Huang, 1991). However, if GPI anchors become 
lyso-forms, they could be cleaved more efficiently. It is possi-
ble that cleavage of a lyso-form of CRI PTO by GPI-PLD might 
occur even before release of the lyso-form from the PM. Because 
many GPI-APs form transient homodimers (Suzuki et al., 2012; 
Seong et al., 2013), CRI PTO might also form homodimers tran-
siently. A homodimer of lyso–GPI-CRI PTO has two acyl chains 
and would be stably associated with the membrane. However, a 
reported t1/2 of transient homodimers of GPI-APs is short (in a 
range of 100–200 ms), and a release from the membrane is ex-
pected to occur during the monomeric state. It was also reported 
that shedding of CRI PTO was mediated by GPI-PLD activity 
(Watanabe et al., 2007). CRI PTO is constantly released into the 
medium in the presence of 10% serum, and serum growth factors 
induce the release of CRI PTO via activation of PLCγ and PKC 
signaling. Thus, PGAP6 might be the target of regulation. Indeed, 
shedding of CRI PTO was inhibited by PGAP6 knockdown even 
in the presence of 10% serum. The regulation of PGAP6 activ-
ity needs to be addressed to better understand the spatiotemporal 
regulation of CRI PTO functions.
Materials and methods
Cells, antibodies, and materials
HEK293T HA-CRI PTO stably expressing HA-tagged CRI PTO was 
established by transfection of linearized pME-pgkpuro-HA-CR1 and 
cultured in DMEM containing 10% FCS and 10 µg/ml puromycin. To 
prepare pME-pgkpuro-HA-CR1, we obtained human CRI PTO cDNA 
(Kazusa DNA Res. Inst.) and cloned it into a mammalian expression 
plasmid pME bearing a puromycin resistance gene and a segment of 
signal sequence plus HA tag (Table S1). 3B2A cells are derived from 
CHO-K1 cells and stably express two human GPI-APs, CD59 and DAF 
(Nakamura et al., 1997). All CHO cell lines, including 3B2A wild-type 
and 3B2A cells stably expressing HFGF-CD59, HA-TMEM8A, HF-
TMEM8A, TMEM8A-Flag, or HA-CRY PTIC (human CRY PTIC HA-
tagged at the N terminus after the ER signal sequence), were cultured 
in Ham’s F-12 medium containing 10% FCS with 6 µg/ml blasticidin, 
10 µg/ml puromycin, or 500 µg/ml hygromycin, if necessary. Human 
CRY PTIC cDNA (clone AK315326) was obtained from NITE Biolog-
ical Resource Center. NTE RA2 cells (clone D1) were obtained from 
ATCC and cultured in DMEM containing 10% FCS. PIGN and GPLD1 
genes were disrupted by the CRI SPR-Cas9 gene editing system (Cong 
et al., 2013) to generate HEK293-PIGN-KO (Ohba et al., 2014) and 
HEK293-GPLD-KO cells, respectively. Antibodies used were mono-
clonal rabbit anti–CRI PTO, polyclonal rabbit anti–Na/K ATPase 1, 
anti-Smad2, and anti–phospho-Smad2 S465/467 (Cell Signaling Tech-
nology); anti-GPP130 (Covance); monoclonal mouse anti–Flag (M2) 
and anti–HA-tag (H7; Sigma-Aldrich); anti-GAP DH (Ambion); anti- 
tubulin and anti-transferrin receptor (Invitrogen); anti–caveolin-1 and 
anti–syntaxin 6 (BD); anti–ribophorin I (Santa Cruz Biotechnology, 
Inc.); and anti-DAF (1A10), anti-CD59 (5H8), and anti-uPAR (5D6; 
Maeda et al., 2007). Mouse anti–human TMEM8A mAb (clone 5C3; 
IgG2b) was a gift from BioLegend. Polyclonal rabbit anti–PGAP6 was 
raised by immunization with a peptide corresponding to the C-terminal 
cytosolic tail of mouse PGAP6 (SCR UM Inc.). Secondary antibodies 
used were HRP-conjugated anti–mouse IgG (GE Healthcare); anti–rab-
bit IgG (Cell Signaling Technology); phycoerythrin-conjugated goat 
anti–mouse IgG (BD); Alexa Fluor 488–conjugated goat anti–mouse 
IgG, goat anti–rabbit IgG, and Alexa Fluor 594–conjugated goat anti–
rabbit IgG (Thermo Fisher Scientific).
Immunoprecipitation of secreted HA-CRI PTO
3B2A cells (5 × 106) were electroporated with 12 µg pME-HA-CRI 
PTO plasmid at 250 V and 1,000 µF using a Gene Pulser (Bio-Rad 
Laboratories). For HEK293T cells (2 × 105), plasmids were transfected 
using Lipofectamine 2000 (Invitrogen) and incubated for 24 h. At 24 or 
52 h after transfection, cells were incubated with serum-free medium 
for 6 h. The culture medium was collected, and anti-HA beads (clone 
HA-CRI PTO and vector or PGAP6 were cultured, and CRI PTO activities in the culture supernatants were assayed as described in Fig. 5 A. Data shown rep-
resent the mean ± SD of three independent experiments. (E and F) CRI PTO was not released from PIGN mutant cells by PGAP6. HEK293 or PIGN-KO cells 
were transfected with HA-CRI PTO and vector or PGAP6. The surface expression of HA-CRI PTO was analyzed by flow cytometry (E). Lines are indicated as 
in A. Geo.MFI and SD of three independent experiments are shown on the right (Student’s t test). The cell lysates and medium samples immunoprecipitated 
with anti-HA beads were analyzed by Western blotting (F). (G) Nodal coreceptor activity is not generated from PIGN-KO cells. PIGN-KO HEK293 cells 
transfected with HA-CRI PTO and vector or PGAP6 were cultured, and CRI PTO activities were assayed as described in Fig. 5 A. Data shown represent the 
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H7) were added and incubated with rotation for 1 h at 4°C. Beads were 
washed four times with PBS. Immunoprecipitated proteins were eluted 
using 4× SDS-PAGE sample buffer and boiled for 5 min. Samples were 
subjected to SDS-PAGE, and proteins were probed by Western blotting.
Triton X-114 partitioning
Triton X-114 partitioning of GPI-APs was performed as described pre-
viously with some modification (Doering et al., 2001). Cells (106) were 
lysed in lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM 
EDTA, complete protease inhibitors [Roche], and 2% Triton X-114) for 
30 min on ice. Supernatants were collected to new tubes and proteins 
precipitated by cold acetone (eight times volume) after incubation for 
1 h at −80°C. After centrifugation, the precipitated proteins were solu-
bilized in lysis buffer, and phase separation was performed by warming 
up to 37°C and subsequent centrifugation at 37°C and 1,000 g for 10 
min. The upper aqueous phase and lower detergent phase were col-
lected and subjected to SDS-PAGE followed by Western blotting to 
determine partitioned proteins.
Figure 7. Pgap6 is required for anterior–posterior 
axis formation in embryos. (A–L) In situ hybridization 
of Pgap6 and Cripto in mouse embryos. Epiblasts in 
E6.2 (A–F) and E6.7 (G–L) mouse embryos expressed 
Pgap6 (A, B, G, and H) and Cripto (E, F, K, and L). 
(C, D, I, and J) Pgap6 sense controls. Bars, 0.5 mm. 
Immunofluorescence analysis of embryo markers in 
wild-type (M) and Pgap6 KO (N, with phenotype; 
O, without phenotype) mice. Whole embryos of 
E6.7 and E8.0 were subjected to immunofluores-
cence analysis with antibodies to Cerl (red in E6.7 
embryos) and Brachyury (cyan in E6.7 embryos 
or red in E8.0 embryos). A, anterior; P, posterior. 
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FACS analysis
HEK293T and 3B2A cells (5 × 106) transfected with plasmids and 
NTE RA2 cells were harvested with PBS containing 5  mM EDTA 
and 0.1% BSA. After washing with FACS buffer (PBS containing 1% 
BSA and 0.1% sodium azide), cells were incubated for 25 min with 
anti-CRI PTO, anti-TMEM8A, anti-DAF, anti-CD59, or anti-HA anti-
bodies (20 µg/ml) on ice. In some cases, cells were treated with phos-
phatidylinositol-specific PLC (PI-PLC) before staining by antibodies. 
For this, four volumes of cells (1.25 × 107/ml in F12 medium without 
FCS) were mixed with one volume of 5 U/ml PI-PLC (from Bacil-
lus cereus; Invitrogen) in PBS supplemented with 0.5% BSA, 5 mM 
EDTA, and 10  mM Hepes and incubated for 1  h at 37°C.  After in-
cubation with antibodies, cells were washed with FACS buffer three 
times. Cells were incubated for 25 min with anti–rabbit Alexa Fluor 
488–conjugated antibody or anti–mouse IgG phycoerythrin-conjugated 
antibody (1:100) on ice. Cells were then pelleted, suspended in 300 µl 
FACS buffer, and analyzed using an FACS Canto II (BD).
Subcellular fractionation
Cells were washed twice with buffer (0.25 M sucrose in 20 mM Hepes-
NaOH, pH 7.4), homogenized three times at 4°C in the same buffer 
using a tight-fitting Dounce pestle, and debris removed by centrifu-
gation at 3,310 g for 10 min. The supernatant was placed on a 2-M 
sucrose cushion and ultracentrifuged at 200,000 g for 1 h. The pellet 
was resuspended and sucrose concentration was adjusted to 1.5 M. A 
discontinuous sucrose gradient was generated in an SW41 tube (Beck-
man Coulter) by overlaying the following sucrose solutions all in buffer 
consisting of 150 mM NaCl and 20 mM Hepes-NaOH, pH 7.4: 1.5 ml 
of 2 M, 2 ml of 1.7 M, 3 ml supernatant, 2 ml of 1.25 M, 2 ml of 0.9 M, 
and 1.5 ml of 0.5 M. The gradient was centrifuged at 110,000 g in an 
SW41 rotor (Beckman Coulter) for 2 h. Fractions were collected from 
the top. Equal aliquots of fractions were subjected to SDS-PAGE and 
proteins probed by Western blotting. Organelles in each fraction were 
identified by determining the PM marker Na/K ATPase 1, ER marker ri-
bophorin I, and Golgi marker syntaxin 6. The His-Flag–tagged PGAP6 
was determined by anti-PGAP6 and anti-Flag antibodies.
Fractionation of GPI-APs with Octyl-FF column
3B2A cells stably transfected with vector or PGAP6 (2 × 107) were 
electroporated with pME-Neo-VSVGts-FF-mEGFP-GPI (Tashima et 
al., 2006). Cells were cultured for 12 h at 37°C followed by 1.5 d at 
32°C and harvested using PBS containing 2.5 mM EDTA and 0.5% 
BSA. After centrifugation, the cell pellet was suspended in 2.5 ml buf-
fer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, and 1 mM EDTA) and 
incubated for 1  h on ice. The supernatants were collected and incu-
bated with anti-Flag (M2) beads overnight. Beads were washed two 
times with 0.5 ml wash buffer 1 (30 mM 1-octyl-β-d-glucoside, 20 mM 
Tris-HCl, pH 7.4, 150 mM NaCl, and 1 mM EDTA), two times with 
0.5  ml wash buffer 2 (20  mM Tris-HCl, pH 7.4, and 0.1% NP-40), 
and two times with 0.5 ml wash buffer 3 (20 mM Tris-HCl, pH 7.4, 
and 0.03% NP-40). Flag-mEGFP-GPI was eluted three times with 
150 µl elution buffer (0.1 M ammonium acetate containing 1 mg/ml 
Flag-peptide [Sigma-Aldrich] and 0.03% NP-40). For PLA2 treatment, 
immunoprecipitates bound to anti-Flag beads were washed, suspended 
in buffer (100 mM Tris-HCl, pH 7.4, 6 mM CaCl2, and 0.1% NP-40), 
and treated with 75 U honeybee PLA2 (Sigma-Aldrich) at 37°C for 
6 h. The beads were washed with wash buffers 2 and 3 and eluted as in a 
similar way. A 100-µl aliquot of the eluate was mixed with 100 µl buffer 
(0.1 M ammonium acetate, 0.03% NP-40, and 10% 1-propanol), loaded 
onto an Octyl-FF column (GE Healthcare), and chromatographed in 
ÄKTA (GE Healthcare) at a flow rate of 0.5 ml/min using a 54–100% 
gradient of 1-propanol. Fractions were collected, dried, subjected to 
SDS-PAGE, and proteins were probed by Western blotting using an 
anti-Flag (M2) antibody.
Immunofluorescence microscopy
3B2A cells (5 × 106) electroporated with HF-PGAP6 together with 
Lyn11-mRFP or RFP-KDEL constructs were cultured for 2 d and fixed 
with 4% PFA in PBS for 25 min at room temperature. After quenching 
with 40 mM ammonium chloride in PBS, the cells were permeabilized 
with or without PBS containing 0.1% Triton X-100 for 1 h at room 
temperature. The cells were stained with mouse anti–TMEM8A or 
anti–Flag with or without rabbit anti–GPP130 followed by Alexa Fluor 
488–conjugated goat anti–mouse IgG with or without Alexa Fluor 594–
conjugated goat anti–rabbit IgG antibodies. Confocal images were ac-
quired on a FluoView FV1000 (Olympus).
Dual luciferase assay
HEK293T cells (8 × 104) were transfected with HA-tagged CRI PTO 
either with an empty vector or PGAP6 plasmid, plus Nodal-responsive 
luciferase reporter construct (Saijoh et al., 2000), FAST2, ALK4, and 
pTK-Renilla using FuGene transfection reagent (Promega). At 24  h 
after transfection, medium was replaced with serum-free medium with 
or without 500 ng/ml recombinant human Nodal (R&D Systems) and 
incubated for 6 h. Luciferase activity was measured using a dual lucif-
erase reporter assay kit (Promega). These experiments were repeated 
three times independently with triplicate samples.
Liquid chromatography/electrospray ionization–tandem mass 
spectrometry analysis
We generated 3B2A cells stably expressing CD59 with tandem His, 
Flag, GST, and Flag-tags at the N terminus after the signal sequence 
(HFGF-CD59; Tashima et al., 2006). The cells were stably transfected 
with an empty vector or PGAP6 and selected in 1 µg/ml puromycin. 
Expressed and released HFGF-CD59 was purified from the culture me-
dium by glutathione Sepharose 4B and eluted with a solution (20 mM 
reduced glutathione, 30  mM Tris-HCl, pH 8.0, and 150  mM NaCl). 
Purified HFGF-CD59 was subjected to SDS-PAGE, stained with Im-
perial CBB (Thermo Fisher Scientific), and digested by trypsin. The 
extracted peptides from the SDS-PAGE gel were directly analyzed by 
liquid chromatography–tandem MS (LC-MS/MS) using an L-column 
(C18, 0.1 × 150 mm; Chemicals Evaluation and Research Institute) 
on a nanoflow LC system (Advance UHP LC; Bruker) coupled to a 
mass spectrometer (TQ Orbitrap Velos; Thermo Fisher Scientific). The 
mass spectrometer was operated in the positive ion mode with data- 
dependent MS/MS. Details were described previously (Tashima et al., 
2006; Fujita et al., 2009).
Knockdown of PGAP6 by siRNA
HEK293T and NTE RA2 cells (2 × 106 cells) were transfected with 
siPGAP6 (sense, 5′-CCU CCA UGA UGA CUA GCG ATT-3′; and anti-
sense, 5′-UCG CUA GUC AUC AUG GAG GTG-3′; Ambion) or siCon-
trol by RNAi MAX reagent (Invitrogen) on day 0 with 30 pmol siRNA 
and on day 1 with 60 pmol siRNA. On day 3, cells were assessed for 
knockdown efficiency by either quantitative PCR or flow cytometry 
and for phenotypic changes.
Whole-mount in situ hybridization
Embryos were carefully staged based on their morphology. They were 
fixed overnight at 4°C in PBS containing 4% PFA, washed twice with 
PBS, and dehydrated with methanol series. Whole-mount in situ hybrid-
ization was performed using standard procedures (Wilkinson, 1992) 
with digoxigenin-labeled riboprobes specific for Cripto (Ding et al., 
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riboprobes for Pgap6 were synthesized from FAN TOM2 cDNA clone 
(AK044384; 2.6 kb). E6.2 and E6.7 embryos were from the ICR strain.
Generation of Pgap6 KO mice
To generate Pgap6/Tmem8a (Mouse Genome Informatics identifica-
tion number 1926283) KO mice, a targeting construct was obtained 
from European Conditional Mouse Mutagenesis. The construct was 
electroporated into EGR-G101 embryonic stem (ES) cells (Fujihara et 
al., 2013a), followed by selection. The ES cells with the construct cor-
rectly targeted into the Pgap6 genomic locus were injected into blas-
tocysts, and chimeric males were obtained. Using the chimeric male 
mice and C57BL/6 female mice, heterozygous KO mice were gener-
ated. Genotyping was performed with a mixture of three PCR primers 
(Fig. S4). The Pgap6 heterozygous KO strains were maintained in a 
C57BL/6 genetic background. All animal experiments were performed 
according to the guidelines for the Care and Use of Laboratory Ani-
mals of Osaka University.
Immunofluorescence analysis of mouse embryos
Embryos were recovered in PBS and carefully staged based on their 
morphology and cell numbers. They were fixed overnight at 4°C in 
PBS containing 4% PFA, washed twice with PBS, permeabilized with 
0.2% Triton X-100 in PBS for 30 min at room temperature, incubated 
for 1 h at room temperature with TSA blocking reagent (PerkinElmer), 
and incubated overnight at 4°C with the following primary antibodies 
diluted in blocking reagent. First immunoreaction was performed with 
goat antibodies to Brachyury (1/50 dilution; N-19, #sc-17743; Santa 
Cruz Biotechnology, Inc.) and rat antibodies to Cerl1 (1/100 dilution; 
MAB1986; R&D Systems). After washing three times with PBS, they 
were incubated with the following secondary antibodies diluted in TSA 
blocking reagent. Second antibodies were Alexa Fluor 488 donkey anti–
mouse IgG (1/200 dilution; A21206; Molecular Probes), Alexa Fluor 
594 donkey anti–rat IgG (1/200 dilution; A21209; Molecular Probes), 
Alexa Fluor 594 donkey anti–goat IgG (1/200 dilution; A11057; Mo-
lecular Probes), and Alexa Fluor 633 donkey anti–goat IgG (1/200 di-
lution; A21082; Molecular Probes). Nuclei were stained by incubation 
for 30 min with DAPI (1/2,000 dilution in PBS; FQ023; Wako Pure 
Chemical Industries). Images were obtained with a laser-scanning con-
focal microscope system (FV1000; Olympus) and a UPL SAPO 20× 
(NA 0.75; Olympus) objective lens. Embryos were genotyped by PCR 
analysis with their parts.
Online supplemental material
Fig. S1 shows that PGAP6 knockdown inhibits release of mature 
CRI PTO from the cell surface even in the presence of serum. Fig. S2 
shows functional analysis of PGAP6 point mutants demonstrating that 
amino acids conserved in the CRE ST superfamily are functionally 
important, except S584A. Fig. S3 shows LC/electrospray ionization 
(ESI)-MS/MS analysis of GPI moiety in HFGF-CD59 shed by PGAP6. 
Fig. S4 shows the procedure and some characteristics of Pgap6 KO 
mice. Table S1 contains primers used in this study.
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